Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia. 2005

M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
Department of Internal Medicine, De Heel Zaans Medisch Centrum, 1500 EE Zaandam, The Netherlands.

BACKGROUND It is sometimes difficult to distinguish between cardia cancer and oesophageal cancer. OBJECTIVE To evaluate whether cytokeratin (CK) expression of the tumour can be of value in differentiating between the two tumour types. METHODS Consecutive patients with a malignant tumour in the oesophagus or stomach were recruited. Biopsy specimens were taken for routine haematoxylin and eosin staining. One tissue block with representative tissue was selected for immunohistochemical staining (CK7 and CK20). RESULTS Endoscopically located adenocarcinoma of the oesophagus was present in 84 patients (64 men, 20 women; mean age, 68 years; range, 44-91). Cancer located primarily in the gastric cardia was present in 63 patients (42 men, 21 women; mean age, 68 years; range, 42-88). The histological diagnosis was metastasis from a primary tumour outside the oesophagus or stomach in 19 patients. The patients were divided into three groups for the immunohistochemical analysis. Patients in group A had definite oesophageal cancer, group B patients had a definite carcinoma located in the gastric cardia, and group C patients had an obstructing tumour distal in the oesophagus at the level of the diaphragm, which could not be passed with the endoscope. Paraffin wax embedded material was available from 122 patients for immunostaining and CK analysis. There was no significant difference in expression or distribution of CK7 or CK20 in the three groups of patients. CONCLUSIONS CK phenotyping cannot distinguish between cancer arising from a Barrett's oesophagus and carcinoma originating in the gastric cardia.

UI MeSH Term Description Entries
D007633 Keratins A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION. Cytokeratin,Keratin Associated Protein,Keratin,Keratin-Associated Proteins,alpha-Keratin,Associated Protein, Keratin,Keratin Associated Proteins,Protein, Keratin Associated,alpha Keratin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002299 Cardia That part of the STOMACH close to the opening from ESOPHAGUS into the stomach (cardiac orifice), the ESOPHAGOGASTRIC JUNCTION. The cardia is so named because of its closeness to the HEART. Cardia is characterized by the lack of acid-forming cells (GASTRIC PARIETAL CELLS). Cardias
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females

Related Publications

M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
April 2001, Histopathology,
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
April 1992, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
October 2000, Scandinavian journal of gastroenterology,
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
November 2003, Histopathology,
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
April 2011, Annals of oncology : official journal of the European Society for Medical Oncology,
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
July 2012, European journal of cancer (Oxford, England : 1990),
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
August 2000, Journal of clinical pathology,
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
January 1997, Digestive diseases (Basel, Switzerland),
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
January 1995, Surgical oncology,
M G F van Lier, and F J Bomhof, and I Leendertse, and M Flens, and A T Balk, and R J L F Loffeld
October 2012, Digestive diseases and sciences,
Copied contents to your clipboard!